Many authors describe that the prevalence of the IgA aB2GP1 in patients with APS or APS-related events can be higher than the prevalence of aPL antibodies included in the Classification Criteria, such as IgM aCL and IgM aB2GP1 [20,35,38,39,42]. Here, ACLY is linked to autoimmune polyendocrinopathy.